Inhalation Sciences Sweden AB
Edit

Inhalation Sciences Sweden AB

http://www.inhalation.se/
Last activity: 11.04.2024
Categories: ResearchProductMedTechToolsScienceEquipmentDrugBioTechLifeIT
We believe in excellence, and we measure it by results. Our clients know that our dry powder aerosol generating platform, PreciseInhale, delivers regional lung data of a quality far beyond other inhalation technologies. PreciseInhale lets them carry out a full PK study using just 50-100 mg of test substance delvering results with a typical standard deviation of <10%.SD. Our in vitro capabilities are widely recognized as world-leading, bringing clients closer than ever to full IVIVC. PreciseInhale can include a series of exposure modules (from in vitro through to in vivo to clinical.) It can generate respirable dry powder aerosols from preclinical cell studies all the way through to human clinical trials, providing a translational ladder for inhalation R&D programs. Visit our website: http://www.inhalation.se/ Visit our labs: We welcome visitors to our labs in Stockholm, Sweden Kliniskt Forskningscentrum KFC Novum plan 6 hiss A Hälsovägen 7 141 57 Huddinge, Sweden Visitor entrance, Blickagången 6, elevator E, level 6
Likes
310
Mentions
93
Location: Sweden, Huddinge
Employees: 11-50
Total raised: $1.24M
Founded date: 2005
Facebook
LinkedIn
Youtube
Email

Investors 2

Funding Rounds 9

DateSeriesAmountInvestors
29.12.2023-$52K-
08.11.2023-$58.36K-
16.10.2023-$199.24K-
25.05.2023-$134.04K-
21.03.2023-$126.29K-
31.01.2023-$87.34K-
23.12.2022-$181.56K-
16.09.2022-$61.91K-
19.10.2021-$340.18K-

Mentions in press and media 93

DateTitleDescriptionSource
11.04.2024Inhalation Sciences AB (publ) releases Annual Report 2023Inhalation Sciences AB (publ) releases Annual Report 2023 Thu, Apr 11, 2024 08:30 CET Report this co...news.cisio...
10.04.2024Inhalation Sciences to present at FDA’s public workshop GDUF...Inhalation Sciences to present at FDA’s public workshop GDUFA on May 20th, 2024 Wed, Apr 10, 2024 08...news.cisio...
11.03.2024Positive results of first-in-human clinical trial of Precise...Positive results of first-in-human clinical trial of PreciseInhale now published in European Journal...news.cisio...
28.02.2024Inhalation Sciences AB (publ) releases Q4 / YE ReportInhalation Sciences AB (publ) releases Q4 / YE Report Wed, Feb 28, 2024 08:30 CET Report this conten...news.cisio...
28.02.2024Inhalation Sciences AB (publ) releases Q4 / YE ReportInhalation Sciences AB (publ) releases Q4 / YE Report Wed, Feb 28, 2024 08:30 CET Report this conten...news.cisio...
22.01.2024Inhalation Sciences signs new partnership with Actarmo Medic...Inhalation Sciences signs new partnership with Actarmo Medical: End-to-end offering for respiratory ...news.cisio...
29.12.2023Inhalation Sciences secures product service contract worth 4...Inhalation Sciences secures product service contract worth 47,000 Euro Fri, Dec 29, 2023 08:30 CET R...news.cisio...
13.12.2023Inhalation Sciences’ captures interest and interaction at it...Inhalation Sciences’ captures interest and interaction at its latest industry webinar ‘Inhaled Biolo...news.cisio...
22.11.2023Inhalation Sciences AB (publ) releases Q3 Report 2023Inhalation Sciences AB (publ) releases Q3 Report 2023 Wed, Nov 22, 2023 08:30 CET Report this conten...news.cisio...
13.11.2023Inhalation Sciences wins new purchase order worth 276,450 Eu...Inhalation Sciences wins new purchase order worth 276,450 Euro (3.2 MSEK) Mon, Nov 13, 2023 08:30 CE...news.cisio...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In